2B Scientific adds business manager to support growth
2B Scientific has appointed Nihad Robinson as business manager.
Robinson joins the Upper Heyford, Oxfordshire firm from Cambridge Biosciences where she was responsible for technical sales in the South UK region. She has a degree in microbiology and a PhD in molecular biology, as well as being fluent in Arabic and French.
"I am very proud to be joining 2BScientific and look forward to helping develop the business," she said.
2B Scientific has also expanded its worldwide supplier network by signing deals with Spring Bioscience and BioDynamics.
"We are excited about our new partnerships with US-based Spring Bioscience and Japan's BioDynamics (Funakoshi)," said James Bernard, md of 2B Scientific. "Both of these companies have established businesses and the expertise that will help position the products successfully in the market."
2B Scientific has extended its catalogue portfolio to include Spring Bioscience's cancer markers and tumour suppressors, plus BioDynamic's Hetero-Stagger PCR Cloning Kit, which enables efficient and fast cloning of PCR products without needing any enzymatic procedures.
The firm also offers products from Acris Antibodies (Germany); Cosmo Bio (Japan); Symansis (New Zealand); and ExBio (Czech Republic), among others.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region